Research Article

IL-1β and IL-6 Upregulation in Children with H1N1 Influenza Virus Infection

Table 1

Clinical and radiological findings, respiratory assessment, and complications of H1N1 infected children. In bold the more severe H1N1 patients.

PatientsFever at first day of admissionDuration of cough (days)SpO2 at admission in room airChest X-rayRespiratory careAntimicrobial therapyComplicationsLength of stay in hospital (days)Outcome (GOS)

1 878%PneumothoraxO supplementation by VentimaskCeftriaxone,  Clarithromycin, and  OseltamivirNone115

2 678%PneumoniaCPAP by Helmet  (1 day) + by VentimaskCeftriaxone,  OseltamivirNone105

3 870%Interstitial pneumonia, pleural effusionNIV by full-face mask, EI/MV  (2 days ), CPAP by Helmet  (4 days)Ceftriaxone,  Clarithromycin, and  OseltamivirPneumorrachis195

4 681%Pneumonia   supplementation by VentimaskCeftriaxone,  OseltamivirNone95

5 782%Bilateral pulmonary infiltrates   supplementation by VentimaskCeftriaxone,  OseltamivirNone95

6 750%Bilateral pulmonary consolidationEI/MV  (11 days), CPAP by Helmet  (4 days)Ceftriaxone,  Clarithromycin, and  OseltamivirNone275

7 676%Bilateral pulmonary infiltrates   supplementation by VentimaskCeftriaxone,  OseltamivirPneumomediastinum115

8 582%Pneumonia   supplementation by Ventimask Ceftriaxone,  OseltamivirPneumopericardium185

9 973%Pneumothorax,  bilateral pulmonary consolidation NIV by full-face maskCeftriaxone,  OseltamivirNone185

10 790Interstitial pneumoniaO2 supplementationKlaritromicin, OseltamivirNone75

11 492NormalO2 supplementationOseltamivirNone45

12 594NormalNoneOseltamivirNone35

13 595NormalNoneOseltamivirNone35

14 691Hyperinflated lungO2 supplementationOseltamivirNone65

15 693NormalNoneOseltamivirNone35

CPAP: continuous positive airway pressure; EI: endotracheal intubation; MV: mechanical ventilation.